NDC 51808-125

In-111 DTPA

In-111 Dtpa

In-111 DTPA is a Intrathecal Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Indium In-111 Pentetate Disodium.

Product ID51808-125_0e714ae6-396c-4488-868e-bfe5fd446f3f
NDC51808-125
Product TypeHuman Prescription Drug
Proprietary NameIn-111 DTPA
Generic NameIn-111 Dtpa
Dosage FormSolution
Route of AdministrationINTRATHECAL
Marketing Start Date2012-06-19
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameAnazaoHealth Corporation
Substance NameINDIUM IN-111 PENTETATE DISODIUM
Active Ingredient Strength4 mCi/1.5mL
Pharm ClassesLead Chelating Activity [MoA],Lead Chelator [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 51808-125-01

1.5 mL in 1 VIAL (51808-125-01)
Marketing Start Date2012-06-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51808-125-01 [51808012501]

In-111 DTPA SOLUTION
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-19
Inactivation Date2019-11-13

Drug Details

Active Ingredients

IngredientStrength
INDIUM IN-111 PENTETATE DISODIUM3.75 mCi/1.5mL

OpenFDA Data

SPL SET ID:aa3bd304-ff60-48a1-8576-be99de02e5f6
Manufacturer
UNII

Pharmacological Class

  • Lead Chelating Activity [MoA]
  • Lead Chelator [EPC]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.